Outcomes of patients with acute kidney injury with regard to time of initiation and modality of renal replacement therapy - first data from the Silesian Registry of Intensive Care Units.

INTRODUCTION: Acute kidney injury (AKI) remains a serious clinical problem in the intensive care unit (ICU). It constitutes an independent risk factor for mortality, especially when renal replacement therapy (RRT) is required. AIM: Due to limited evidence pertaining to timing, choice of RRT modality and lack of studies investigating AKI in Polish ICUs, we sought to analyse outcomes of adult AKI-RRT ICU patients in the Silesian Voivodeship.
MATERIAL AND METHODS: We analysed data regarding 1,380 patients with AKI who required RRT (AKI-RRT) (9.2% of all subjects in the registry) hospitalized between October 2011 and December 2014 in Silesian ICUs. The primary outcome was crude ICU mortality. Length of ICU stay (LOS) was considered the secondary outcome.
RESULTS: Of 15,030 patients 1,380 (9.2%) individuals developed AKI requiring RRT. The overall mortality in the registry was 43.9%, but it was significantly higher (69.1%) in AKI-RRT patients (p < 0.01). Mortality with regard to timing of institution of RRT was 67.1% in the group with RRT instituted prior to ICU admission (RRT-prior-ICU) and 69.4% in patients with RRT instituted during ICU hospitalization (RRT-in-ICU) (p = 0.58).
CONCLUSIONS: Multiple patient- and hospitalization-related factors determine mortality in this specific cohort. There are no differences in mortality with regard to RRT being initiated before or during hospitalization in the ICU. Due to multiple confounders, differences in mortality in terms of modality of RRT should be interpreted with caution.

Introduction

Acute kidney injury (AKI) remains a serious clinical problem in intensive care units (ICU) due to its high frequency, complex pathophysiology and significant impact on the outcomes [1-3]. It constitutes an independent risk factor for mortality, especially when renal replacement therapy (RRT) is required [4].

Multiple factors may influence the prognosis in patients with AKI, including advanced age, worsening of general health status, diminished pre-morbid functional performance, need of hospitalization before ICU admission, late onset of AKI, co-morbidities and their severity [5, 6]. However, Ostermann and Chang [7] found that the outcome of subjects was directly associated with AKI staging, progression of organ failure, nonsurgical admission, and admission following emergency surgery. In the largest multinational, multicentre study of AKI patients in ICU to date, the BEST Kidney trial [8], the investigators found that AKI occurring during hospitalization has exceptionally dismal prognosis.

The outcome of patients with AKI who require RRT (AKI-RRT) is even worse because it is usually applied when pharmacological treatment is insufficient or contraindicated [4]. Unfortunately, there are no universal criteria for initiation of RRT in AKI and modality of therapy. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines only state that RRT is to be initiated emergently when life-threatening disturbances in fluid, electrolyte or acid-base balance exist and recommend considering the broader clinical context (not graded). The KDIGO AKI guidelines also find continuous and intermittent therapies as complementary, although there are clinical situations where continuous therapies are preferable, namely hemodynamic instability, acute brain injury and other causes of increased intracranial pressure [9].

Increasing evidence suggests improved outcome in AKI patients with early institution of RRT [10-12]. However, this question has not been answered by large randomised controlled trials (RCTs) yet. To our knowledge, only one single RCT has been conducted to evaluate the impact of timing of RRT on outcome, and it found no differences in hospital mortality between patients treated early (within 12 hours of oliguria) and patients treated late (i.e. classic indications for RRT) [13].

Aim

In view of the limited evidence relating to issues of timing of initiation and choice of RRT modality and lack of studies investigating AKI in Polish ICUs, we sought to analyse outcomes of adult AKI-RRT ICU patients in the Silesian Voivodeship.

Material and methods

This study was carried out as an observational multicentre registry. It comprised adult patients treated in Silesian Voivodeship ICUs in Poland. At the time of data extraction (i.e. December 31, 2014) there were 15,030 records in the registry. All consecutive patients who required RRT during or prior to hospitalization in an ICU, independent of the modality of RRT, were screened (n = 1566). Subjects with pre-existing end-stage chronic kidney disease were excluded (n = 186).

Finally, we analysed data regarding 1,380 patients with AKI who required RRT (AKI-RRT) (9.2% of all subjects in the registry) hospitalized between October 2011 and December 2014, of whom 146 (10.6%) individuals had RRT initiated before ICU admission (RRT-prior-ICU) and 1234 (89.4%) subjects had RRT started during the ICU stay (RRT-in-ICU). The AKI was defined as acute deterioration of kidney function requiring initiation of RRT and corresponds to class 3 of AKI in the AKIN (Acute Kidney Injury Network) classification [9] and class F (Failure) in the RIFLE classification [9]. Initiation of RRT was at the discretion of a treating physician as there was no protocol for initiation of therapy.

Available demographic and clinical data were retrieved. They included 100 variables organized in 24 categories regarding pre-admission period, time of admission and ICU stay. The primary outcome was crude ICU mortality. Length of ICU stay (LOS) was considered the secondary outcome.

The study was approved by the Ethics Committee of the Medical University of Silesia. Due to the non-interventional and anonymous nature of the study, the Ethics Committee waived the requirement for informed consent.

Statistical analysis

Statistical analysis was performed using licensed MedCalc version 16.1 (MedCalc Software bvba, Ostend, Belgium) statistical software. Continuous variables are presented as median and interquartile range (IQR, i.e. 25th-75th percentile), whereas categorical variables are presented as percentages. All variables were tested for normal distribution using the Shapiro-Wilk test. Between-group differences for continuous variables were assessed using the Kruskal-Wallis test and post-hoc analysis (if applicable). For categorical variables the χ2 test was used. The possible impact of the clinical and demographic parameters on mortality was initially screened by bivariate analyses. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Variables with a p-value < 0.05 were consecutively subjected to a multivariate analysis. The forward logistic regression method was applied. Logistic ORs with 95% CIs were subsequently estimated. The p-value < 0.05 was considered statistically significant.

Results

Of 15,030 patients 1,380 (9.2%) individuals developed AKI requiring RRT. RRT was instituted prior to ICU admission in 146 (10.6%) patients and in 1234 (89.4%) patients during ICU hospitalization. Median age was 66 (IQR 56-75) years, and there were 495 (35.9%) females among all AKI-RRT patients.

Demographic and clinical data according to timing of initiation and modality of RRT are depicted in detail in Tables I–VI.

Tab. I

Pre-intensive care units (ICU) admission clinical data

Variable	All(n = 1380)	RRT-prior-ICU(n = 146)	RRT-in-ICU(n = 1234)	OR (95% CI)	P-value
Age [years]	66 (56-75)	66.5 (57-74)	66 (56-75)	1.02 (1.01-1.02)	0.87
Females	495 (35.9)	51 (34.9)	444 (35.9)	0.96 (0.67-1.37)	0.80
Hospitalization prior to ICU [days]	2 (1-8)	7 (1-15)	2 (1-7)	1.01 (0.99-1.03)	< 0.001
Alcohol abuse	140 (10.1)	8 (5.5)	132 (10.7)	0.48 (0.23-1.01)	0.05
Auto-aggressive systemic disease	38 (2.7)	3 (2.1)	35 (2.8)	0.72 (0.22-2.37)	0.59
Malignancies	62 (4.5)	3 (2.1)	59 (4.8)	0.42 (0.13-1.35)	0.14
CAD	690 (50.0)	81 (55.5)	609 (49.4)	1.28 (0.91-1.81)	0.16
DM	423 (30.6)	39 (26.7)	384 (31.1)	0.81 (0.55-1.19)	0.28
Cachexia (BMI < 18.5 kg/m2)	51 (3.7)	0 (0.0)	51 (4.1)	0.08 (0.00-1.28)	0.07
Arterial hypertension	726 (52.6)	78 (53.4)	648 (52.5)	1.04 (0.74-1.46)	0.83
Previous stroke	81 (5.9)	14 (9.6)	67 (5.4)	1.85 (1.01-3.38)	0.046
Solid organ transplantation	9 (0.6)	1 (0.7)	8 (0.6)	1.06 (0.13-8.51)	0.96
CHF	622 (45.1)	66 (45.2)	556 (45.1)	1.01 (0.71-1.42)	0.97
CKD	442 (32.0)	58 (39.7)	382 (31.1)	1.46 (1.03-2.08)	0.04
CRF	130 (9.4)	10 (6.8)	120 (9.7)	0.68 (0.35-1.22)	0.26
Chronic neurologic disease	61 (4.4)	8 (5.5)	53 (4.3)	1.29 (0.60-2.77)	0.51
Atherosclerosis	530 (38.4)	65 (44.5)	465 (37.7)	1.33 (0.94-1.88)	0.11
Obesity (BMI > 35 kg/m2)	94 (6.8)	11 (7.5)	83 (6.7)	1.13 (0.59-2.17)	0.71
Primary ICU admission diagnosis
Severe sepsis	249 (18.0)	17 (11.6)	232 (18.8)	0.57 (0.34-0.96)	0.04
Severe metabolic disorder	143 (10.4)	20 (13.7)	123 (9.9)	1.43 (0.86-2.38)	0.16
Infection	315 (22.8)	38 (26.0)	277 (22.4)	1.21 (0.82-1.80)	0.33
Circulatory insufficiency	752 (54.5)	96 (65.7)	656 (53.2)	1.69 (1.18-2.42)	0.004
MODS	359 (26.0)	36 (24.7)	323 (26.2)	0.92 (0.62-1.37)	0.69
SCA	278 (20.1)	25 (17.1)	253 (20.5)	0.80 (0.51-1.26)	0.34
Acute respiratory failure	926 (67.1)	111 (76.0)	815 (66.0)	1.63 (1.09-2.43)	0.02
Acute neurologic disease	41 (2.9)	5 (3.4)	36 (2.9)	1.18 (0.46-3.06)	0.73
SAP	60 (4.3)	4 (2.7)	56 (4.5)	0.59 (0.21-1.66)	0.32
Post-surgical status	446 (32.3)	69 (47.3)	377 (30.6)	2.04 (1.44-2.88)	< 0.001
TBI	17 (1.2)	0 (0.0)	17 (1.4)	0.24 (0.01-3.97)	0.32
Multiple trauma	35 (2.5)	0 (0.0)	35 (2.8)	0.11 (0.01-1.89)	0.13
Shock	548 (39.7)	56 (38.4)	492 (39.9)	0.94 (0.66-1.33)	0.72
Obtunded consciousness	512 (37.1)	66 (45.2)	446 (36.1)	1.46 (1.03-2.06)	0.03
Acute-on-chronic respiratory failure	70 (5.1)	7 (4.8)	63 (5.1)	0.94 (0.42-2.08)	0.87
Poisoning	24 (1.74)	0 (0.0)	24 (1.9)	0.17 (0.01-2.79)	0.21
Direct ICU admission diagnosis
Circulatory insufficiency	1063 (77.0)	111 (76.0)	952 (77.1)	0.94 (0.63-1.40)	0.76
Renal failure	806 (58.4)	115 (78.8)	691 (55.9)	2.92 (1.93-4.40)	< 0.001
Respiratory failure	1217 (88.2)	130 (89.0)	1087 (88.1)	1.09 (0.64-1.89)	0.74
Multiple trauma	40 (2.9)	2 (1.4)	38 (3.1)	0.44 (0.10-1.83)	0.26
Metabolic disorders	579 (41.9)	63 (43.1)	516 (41.8)	1.06 (0.75-1.49)	0.76
Obtunded consciousness	782 (56.7)	87 (59.6)	695 (56.3)	1.14 (0.81-1.62)	0.45

CAD – coronary artery disease, DM – diabetes mellitus, BMI – body mass index, CHF – congestive heart failure, CKD – chronic kidney disease, MODS – multiple organ dysfunction syndrome, SCA – sudden cardiac arrest, SAP – severe acute pancreatitis, TBI – traumatic brain injury.

Tab. VI

Clinical data during intensive care units (ICU) stay

Variable	All(n = 1380)	IHD(n = 180)	CRRT(n = 1118)	IHD + CRRT(n = 82)	P-value
Catecholamines	1290 (93.5)	163 (90.6)	1049 (93.8)	78 (95.1)	0.21
Antibiotics	1282 (92.9)	167 (92.8)	1040 (93.0)	75 (91.5)	0.87
ECMO	27 (2.0)	0 (0.0)	26 (2.3)	1 (1.2)	0.09
IABP	95 (6.9)	4 (2.2)	89 (7.9)	2 (2.4)	0.0049
Intubation	979 (70.9)	131 (72.8)	781 (69.9)	67 (81.7)	0.06
NO	36 (2.6)	0 (0.0)	35 (3.1)	1 (1.2)	0.04
Surgery in ICU	295 (21.4)	24 (13.3)	250 (22.4)	21 (25.6)	0.01
Tracheostomy	324 (23.5)	33 (18.3)	259 (23.2)	32 (39.0)	0.001
Invasive ventilation	1193 (86.4)	155 (86.1)	963 (86.1)	75 (91.5)	0.39

ECMO – extracorporeal membrane oxygenation, IABP – intra-aortic balloon pump, NO – nitric oxide.

The overall mortality in the registry was 43.9%, but it was significantly higher (69.1%) in AKI-RRT patients (p < 0.01). Mortality with regard to timing of institution of RRT was 67.1% in the group with RRT instituted prior to ICU admission (RRT-prior-ICU) and 69.4% in patients with RRT instituted during ICU hospitalization (RRT-in-ICU) (p = 0.58) (Fig. 1). Mortality in internitent hemodialysis (IHD), continuous RRT (CRRT), IHD + CRRT subgroups were 62.2%, 69.9%, 74.4%, respectively (p = 0.02) (Fig. 2).

Fig. 1

Mortality of patients according to time of RRT institution. P < 0.05: all vs. AKI-RRT; all vs. RRT-prior-ICU; all vs. RRT-in-ICU

Fig. 2

Mortality of patients according to RRT modality. P < 0.05: all vs. AKI-RRT; all vs. IHD; all vs. CRRT; all vs. IHD + CRRT

Median ICU LOS in all AKI-RRT subjects was 9.8 (IQR: 4.0-18.7) days, and it was longer compared to the non-AKI-RRT group (9.8 (IQR: 4.0-19) vs. 5.7 (IQR: 2.1-12) days; p < 0.001, respectively). Median ICU LOS in the RRT-prior-ICU group was 9.5 (IQR: 4.2-16.2) and in the RRT-in-ICU group was 9.8 (IQR: 4-18.8). Median ICU LOS in IHD, CRRT and IHD + CRRT groups was 8.6 (IQR: 3.4-17.3), 9.6 (IQR: 3.9-18.2) and 16.5 (IQR: 8.0-27.3) days, respectively.

After adjustment for timing of initiation and modality of RRT, six variables remained statistically significant predictors of mortality (Table VII). APACHE II score on admission, multiple organ dysfunction syndrome (MODS) as primary admission diagnosis, atherosclerosis in medical history and CRRT as modality of RRT increased mortality. Renal failure as direct admission diagnosis and multiple trauma as primary admission diagnosis reduced the risk of death.

Tab. VII

Multiple regression analysis

Independent variable	Coefficient ±standard error	P-value
Modality of RRT	0.07 ±0.04	0.045
Direct admission diagnosis – renal failure	–0.11 ±0.04	0.005
Atherosclerosis	0.09 ±0.04	0.012
Primary admission diagnosis – MODS	0.13 ±0.05	0.006
Primary admission diagnosis – multiple trauma	–0.24 ±0.10	0.023
APACHE II	0.01 ±0.002	< 0.001

Discussion

In this comprehensive registry study we sought to investigate the importance of timing of initiation and choice of RRT in AKI patients hospitalised in ICUs in the Silesian Voivodeship.

Based on a large multicentre medical database, we found that the prevalence of AKI requiring RRT in the Silesian Voivodeship was about 10%. This finding is comparable to the results of Nisula (10.2%) [14] and Uchino (5-6%) [8].

The AKI subjects receiving RRT constitute a group of patients with particularly dismal prognosis. Mortality of AKI-RRT patients reached 62.2-74.4% depending on the timing of initiation and modality of RRT and was significantly higher than in non-AKI-RRT patients (43.9% overall mortality in the registry). Hospital mortality of AKI-RRT patients in the present study was higher than in previous studies (Nisula – 25.6% [14]; Mehta – 37% [15]; Ostermann – 56.8% [7]; Uchino – 60% [8]), which is probably due to different inclusion criteria of RRT administration and study group characteristics. The high hospital mortality of AKI-RRT patients in our study might also be due to high severity of illness as per the APACHE II score of 26 (IQR: 20-32), which corresponds to predicted mortality of 55% [16].

There are different definitions regarding timing of institution of RRT. In our study we considered RRT initiated prior to ICU admission as early and that instituted during hospitalization in the ICU as late RRT. The AKI constitutes an indication for ICU admission, so RRT initiated before admission to the ICU might in fact be considered as early. However, there are no universal and widely accepted definitions for early and late initiation of RRT. In the only RCT in this field, that of Bouman et al. [13], the early RRT group initiated therapy within 12 hours of oliguria defined according to the authors as urine output (UO) < 30 ml/hours for 6 hours not responding to diuretics or hemodynamic optimization or creatinine clearance (CrCl) < 20 ml/min. The same authors defined late RRT when classic indications for RRT were met. The investigators did not find any differences in ICU or hospital mortality between early and late RRT groups. These results reflects our findings, although definitions for timing of RRT were different. In some prospective observational studies it was found that initiation of RRT at lower blood urea nitrogen (BUN) concentrations or closer to ICU admission is beneficial for survival. In the PICARD study [7] initiation of RRT at BUN > 76 mg/dl was associated with higher mortality (OR = 1.85; 95% CI: 1.16-2.96). In the study by Bagshaw et al. [10], early RRT was initiated at BUN < 67.8 mg/dl (24.2 mmol/l), and timing of RRT was also categorized temporally from ICU admission into early (< 2 days), delayed (2-5 days) and late (> 5 days). The authors found no difference in mortality with regards to BUN concentration, but late initiation of RRT as per temporal categories was associated with higher crude mortality, longer RRT, longer ICU LOS and greater dialysis dependence. Late initiation of RRT as per RIFLE criteria was identified as an independent predictor of mortality [17]. Disagreement of these results with the findings from our study might be due to different pathophysiology of AKI present before and on admission to the ICU and occurring late during hospitalization in the ICU.

Regarding RRT modality, the findings from our study favour IHD as opposed to CRRT (crude hospital mortality 62.2 vs. 69.9%). Although there are some differences between IHD and CRRT, hard end-points of most studies do not favour any particular RRT modality. A meta-analysis comprising 1550 patients found no differences between CRRT and IHD as regards hospital mortality, ICU mortality, LOS and renal recovery [18]. However, some observational studies suggest that CRRT may be beneficial in restoring renal function in survivors [19]. One should bear in mind that IHD and CRRT groups differed significantly in terms of Therapeutic Intervention Scoring System-28 (TISS-28), intra-aortic balloon pump (IABP), nitric oxide (NO) use. The CRRT was also a treatment of choice in more haemodynamically compromised patients (Tab. II, III). Therefore, the differences in mortality should be interpreted with caution.

Tab. II

Clinical data on intensive care units (ICU) admission

Variable	All(n = 1380)	RRT-prior-ICU(n = 146)	RRT-in-ICU(n = 1234)	OR (95% CI)	P-value
APACHE II	26 (20-32)	26 (20-33)	26 (20-32)	1.04 (1.03-1.06)	0.74
GCS	7 (3-13)	6 (3-11)	7 (3-13)	0.91 (0.89-0.94)	0.14
SAPS III	64 (45-81)	64 (43.5-79.5)	64 (45-81)	1.01 (1.00-1.02)	0.71
24 h TISS-28	39 (33-45)	39 (34.5-44)	39 (33-45)	1.03 (1.01-1.04)	0.94
Catecholamines	833 (60.4)	115 (78.8)	718 (58.2)	2.67 (1.76-4.03)	< 0.001
Obtunded	901 (65.3)	103 (70.5)	798 (64.7)	1.31 (0.89-1.90)	0.16
Endocavital stimulation	21 (1.5)	2 (1.4)	19 (1.5)	0.89 (0.20-3.85)	0.87
Mechanical ventilation	1004 (72.7)	122 (83.6)	882 (71.5)	2.03 (1.29-3.19)	0.002
Intubated	1009 (73.1)	122 (83.6)	887 (71.9)	1.99 (1.26-3.13)	0.003

APACHE II – Acute Physiology and Chronic Health Evaluation II, GCS – Glasgow Coma Scale, SAPS – Simplified Acute Physiology Score III, TISS-28 – Therapeutic Intervention Scoring System-28.

Tab. III

Clinical data during intensive care units (ICU) stay

Variable	All(n = 1380)	RRT-prior-ICU(n = 146)	RRT-in-ICU(n = 1234)	OR (95% CI)	P-value
Catecholamines	1290 (93.5)	132 (90.4)	1158 (93.8)	0.62 (0.34-1.12)	0.12
Antibiotics	1282 (92.9)	136 (93.1)	1146 (92.9)	1.04 (0.53-2.06)	0.90
ECMO	27 (1.9)	6 (4.1)	21 (1.7)	2.47 (0.98-6.24)	0.05
IABP	95 (6.9)	16 (10.9)	79 (6.4)	1.79 (1.02-3.17)	0.04
Intubation	979 (70.9)	102 (69.9)	877 (71.1)	0.94 (0.65-1.37)	0.76
NO	36 (2.6)	7 (4.8)	29 (2.3)	2.09 (0.89-4.87)	0.08
Surgery in ICU	295 (21.4)	20 (13.7)	275 (22.3)	0.55 (0.34-0.90)	0.02
Tracheostomy	324 (23.5)	37 (25.3)	287 (23.3)	1.12 (0.75-1.66)	0.57
Invasive ventilation	1193 (86.4)	123 (84.2)	1070 (86.7)	0.82 (0.51-1.32)	0.41
Non-invasive ventilation	84 (6.1)	3 (2.1)	81 (6.6)	0.29 (0.09-0.96)	0.04

ECMO – extracorporeal membrane oxygenation, IABP – intra-aortic balloon pump, NO – nitric oxide.

Apart from RRT modality, we found other determinants of compromised outcome in AKI-RRT patients (Tab. V). The AKI-RRT patients with higher severity of illness are more likely to die, which in our study is exemplified by increased risk for mortality in patients with MODS as the primary admission diagnosis and in patients with a higher APACHE II score. We found multiple trauma as the primary admission diagnosis to reduce mortality in this cohort of patients, which corresponds to the results of other authors [20].

Tab. V

Clinical data on intensive care units (ICU) admission

Variable	All(n = 1380)	IHD(n = 180)	CRRT(n = 1118)	IHD + CRRT(n = 82)	P-value
APACHE II	26 (20-32)	28 (22.5-33.5)	25 (19-32)	27 (21-32)	0.09
GCS	7 (3-13)	6 (3-12)	7 (3-13)	8 (3-14)	0.65
SAPS III	64 (45-81)	75 (57.5-88)	61.5 (41-79)	68.5 (57-77)	< 0.001
24 h TISS-28	39 (33-45)	37 (32-41.25)	39 (33-45)	36.5 (32-41)	< 0.001
Catecholamines	833 (60.4)	119 (66.1)	667 (59.7)	47 (57.3)	0.22
Obtunded	901 (65.3)	126 (70.0)	717 (64.1)	58 (70.7)	0.17
Endocavital stimulation	21 (1.5)	1 (0.6)	17 (1.5)	3 (3.7)	0.16
Mechanical ventilation	1004 (72.8)	146 (81.1)	799 (71.5)	59 (71.9)	0.03
Intubated	1009 (73.1)	144 (80.0)	804 (71.9)	61 (74.4)	0.07

APACHE II – Acute Physiology and Chronic Health Evaluation II, GCS – Glasgow Coma Scale, SAPS – Simplified Acute Physiology Score III, TISS-28 – Therapeutic Intervention Scoring System-28.

Fluid management also contributes to the course and outcome of AKI. Colloids should be avoided at all costs, especially in shock patients [21]. There is also a U-shaped association between fluid balance and risk of AKI with corresponding mortality [22, 23]. Fluid overload is a confirmed, independent factor increasing incidence and severity of AKI [24]. Moreover, higher cumulative fluid balance is associated with short-term mortality following AKI [24, 25]. Therefore, the early therapeutic intervention and diagnostic approach plays a key role in improving prognosis in AKI patients. Even minor increases in creatinine concentration are associated with adverse outcomes [26]. Novel biomarkers are suggested to expedite diagnosis of AKI [27].

Our study has several limitations. First, we lacked some important clinical data, including creatinine concentration, fluid balance, timing of RRT, which might have influenced the outcome in the AKI-RRT population. However, entering all these additional parameters into a large database would take enormous effort on the part of attending physicians and potentially discourage them from reporting. One has to bear in mind that reporting was entirely voluntary and the registry was not set up to specifically research AKI. Second, there were no accurate definitions for some conditions given, e.g. a broad definition of shock without specifying what type should be considered: cardiogenic, haemorrhagic, anaphylactic, etc. Finally, the observational nature of our project is an obvious limitation of all registries, as it may lead to a systematic error. However, the large number of patients analysed may compensate for this drawback. Being aware of all shortcomings, the above-presented clinical evidence should attract the attention of an international audience, as it is the first such profound insight into the problem of AKI-RRT in Polish ICUs.

Conclusions

Prognosis of patients with acute kidney injury and receiving renal replacement therapy in Silesian ICUs is unfavourable. Multiple patient- and hospitalization-related factors determine mortality in this specific cohort. There are no differences in mortality with regard to RRT being initiated before or during hospitalization in the ICU. Due to multiple confounders, differences in outcome in terms of modality of RRT should be interpreted with caution.

Tab. IV

Pre-intensive care units (ICU) admission clinical data

Variable	All(n = 1380)	IHD(n = 180)	CRRT(n = 1118)	IHD + CRRT(n = 82)	P-value
Age [years]	66 (56-75)	68 (57.5-76)	66 (56-74)	66.5 (52-74)	0.25
Females	495 (35.9)	71 (39.4)	399 (35.7)	25 (30.5)	0.36
Hospitalisation prior to ICU [days]	2 (1-8)	2 (0-6)	3 (1-8)	1.5 (0-6)	0.006
Alcohol abuse	140 (10.1)	16 (8.9)	117 (10.5)	7 (8.5)	0.72
Malignancies	62 (4.5)	9 (5.0)	50 (4.5)	3 (3.7)	0.89
CAD	690 (50.0)	93 (51.7)	554 (49.6)	43 (52.4)	0.78
DM	423 (30.7)	63 (35.0)	338 (30.2)	22 (26.8)	0.32
Cachexia (BMI < 18.5 kg/m2)	51 (3.7)	4 (1.7)	48 (4.3)	0 (0.0)	0.04
Arterial hypertension	726 (52.6)	92 (51.1)	586 (52.4)	48 (58.5)	0.51
Solid organ transplantation	9 (0.7)	0 (0.0)	8 (0.7)	1 (1.2)	0.44
CHF	622 (45.1)	77 (42.8)	513 (45.9)	32 (39.0)	0.39
Chronic neurologic disease	61 (4.4)	10 (5.6)	48 (4.3)	3 (3.7)	0.70
Atherosclerosis	530 (38.4)	77 (42.8)	412 (36.8)	41 (50.0)	0.02
Obesity (BMI > 35 kg/m2)	94 (6.8)	14 (7.8)	72 (6.4)	8 (9.8)	0.44
Primary ICU admission diagnosis
Severe sepsis	249 (18.0)	23 (12.8)	208 (18.6)	18 (21.9)	0.039
Severe metabolic disorder	143 (10.4)	25 (13.9)	108 (9.7)	10 (12.2)	0.190
Infection	315 (22.8)	43 (23.9)	246 (22.0)	26 (31.7)	0.121
Circulatory insufficiency	752 (54.5)	102 (56.7)	603 (53.9)	47 (57.3)	0.688
MODS	359 (26.0)	28 (15.6)	308 (27.5)	23 (28.0)	0.003
SCA	278 (20.1)	47 (26.1)	213 (19.1)	18 (21.9)	0.083
Acute respiratory failure	926 (67.1)	136 (75.6)	725 (64.8)	65 (79.3)	0.001
Acute neurologic disease	41 (3.0)	8 (4.4)	30 (2.7)	3 (3.7)	0.404
SAP	60 (4.3)	4 (2.2)	48 (4.3)	8 (9.8)	0.02
Post-surgical status	446 (32.3)	40 (22.2)	377 (33.7)	29 (35.4)	0.008
TBI	17 (1.2)	2 (1.1)	14 (1.2)	1 (1.2)	0.99
Multiple trauma	35 (2.5)	0 (0.0)	33 (2.9)	2 (2.4)	0.06
Shock	548 (39.7)	69 (38.3)	442 (39.5)	37 (45.1)	0.56
Obtunded consciousness	512 (37.1)	76 (42.2)	402 (35.9)	34 (41.5)	0.19
Acute-on-chronic respiratory failure	70 (5.1)	9 (5.0)	58 (5.2)	3 (3.7)	0.83
Poisoning	24 (1.7)	5 (2.8)	16 (1.4)	3 (3.7)	0.17
Direct ICU admission diagnosis
Circulatory insufficiency	1063 (77.0)	126 (70.0)	879 (78.6)	58 (70.7)	0.0145
Renal failure	806 (58.4)	108 (60.0)	650 (58.1)	48 (58.5)	0.89
Respiratory failure	1217 (88.2)	166 (92.2)	977 (87.4)	74 (90.2)	0.147
Multiple trauma	40 (2.9)	1 (0.6)	37 (3.3)	2 (2.4)	0.119
Metabolic disorders	579 (42.0)	66 (36.7)	470 (42.0)	43 (52.4)	0.0215
Obtunded consciousness	782 (56.7)	103 (57.2)	630 (56.3)	49 (59.8)	0.846

CAD – coronary artery disease, DM – diabetes mellitus, BMI – body mass index, CHF – congestive heart failure, MODS – multiple organ dysfunction syndrome, SCA – sudden cardiac arrest, SAP – severe acute pancreatitis, TBI – traumatic brain injury.